Combinations of class-I specific histone deacetylase inhibitors with proteasome inhibitors

Details for Australian Patent Application No. 2007296259 (hide)

Owner Janssen Pharmaceutica NV

Inventors Page, Martin John; Janicot, Michel Marie Francois; Arts, Janine; Hellemans, Peter Willem Jan

Agent Shelston IP

Pub. Number AU-A-2007296259

PCT Pub. Number WO2008/031820

Priority 06120742.9 15.09.06 EP

Filing date 11 September 2007

Wipo publication date 20 March 2008

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/69 (2006.01) - Boron compounds

A61K 38/05 (2006.01) Medicinal preparations containing peptides - Dipeptides

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

14 May 2009 PCT application entered the National Phase

  PCT publication WO2008/031820 Priority application(s): WO2008/031820

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007296263-Quinolinylmethyl compounds

2007296256-Histone deacetylase inhibitors with combined activity on class-I and classIIB histone deacetylases in combination with proteasome inhibitors